Antioxidant and prooxidant effects of quercetin on glyceraldehyde-3-phosphate dehydrogenase

Food and Chemical Toxicology - Tập 45 - Trang 1988-1993 - 2007
E.V. Schmalhausen1, E.B. Zhlobek1, I.N. Shalova2, O. Firuzi3, L. Saso3, V.I. Muronetz1,2
1Belozersky Institute of Physico-Chemical Biology, Moscow State University, 119992, Moscow, Russia
2School of Bioengineering and Bioinformatics, Moscow State University, 11992 Moscow, Russia
3Department of Human Physiology and Pharmacology “Vittorio Erspamer”, University of Rome “La Sapienza”, 00185 Rome, Italy

Tài liệu tham khảo

Afanas’ev, 1989, Chelating and free radical scavenging mechanism of inhibitory action of rutin and quercetin in lipid peroxidation, Biochem. Pharmacol., 38, 1763, 10.1016/0006-2952(89)90410-3 Arutyunova, 2003, Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids, Biochem. Biophys. Res. Commun., 307, 547, 10.1016/S0006-291X(03)01222-1 Bors, 1987, Radical scavenging by flavonoid antioxidants, Free Radical Res. Commun., 2, 289, 10.3109/10715768709065294 Bors, 1994, Flavonoid antioxidants: rate constants for reactions with oxygen radicals, Methods Enzymol., 234, 420, 10.1016/0076-6879(94)34112-5 Buettner, 1990, Ascorbate oxidation: UV absorbance of ascorbate and ESR spectroscopy of the ascorbyl radical as assays for iron, Free Radical Res. Commun., 10, 5, 10.3109/10715769009145927 Butterfield, 2002, Amyloid beta-peptid (1-42) induced oxidative stress and neurotoxicity: implication for neurodegeneration in Alzheimer’s disease brain, Free Radical Res., 36, 1307, 10.1080/1071576021000049890 Butterfield, 2001, Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins, Mech. Ageing Dev., 122, 945, 10.1016/S0047-6374(01)00249-4 Cane, 1994, Inhibition of glyceraldehyde-3-phosphate dehydrogenase by pentalenolactone. 2. Identification of the site of alkylation by tetrahydropentalenolactone, Biochemistry, 33, 6524, 10.1021/bi00187a020 Cao, 1997, Antioxidant and prooxidant behavior of flavonoids: structure–activity relationships, Free Radical Biol. Med., 22, 749, 10.1016/S0891-5849(96)00351-6 Conquer, 1998, Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects, J. Nutr., 128, 593, 10.1093/jn/128.3.593 da Silva, 1998, Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma, FEBS Lett., 430, 405, 10.1016/S0014-5793(98)00709-1 Danshina, 2001, Mildly oxidized glyceraldehyde-3-phosphate dehydrogenase as a possible regulator of glycolysis, JUBMB Life, 51, 309 Ferry, 1996, Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition, Clin. Cancer Res., 2, 659 Good, 1996, Evidence of neuronal oxidative damage in Alzheimer’s disease, Am. J. Pathol., 149, 21 Halliwell, 2001, Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment, Drugs Aging, 18, 685, 10.2165/00002512-200118090-00004 Hayek, 1997, Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation, Arterioscler Thromb. Vasc. Biol., 17, 2744, 10.1161/01.ATV.17.11.2744 Ishitani, 2003, Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs, Prog. Neuropsychopharmacol. Biol. Psychiat., 27, 291, 10.1016/S0278-5846(03)00024-1 Jovanovic, 1994, Flavonoids as antioxidants, J. Am. Chem. Soc., 116, 4846, 10.1021/ja00090a032 Laughton, 1989, Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA, Biochem. Pharmacol., 38, 2859, 10.1016/0006-2952(89)90442-5 Lyras, 1997, An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer’s disease, J. Neurochem., 68, 2061, 10.1046/j.1471-4159.1997.68052061.x Lyras, 1998, Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodi, J. Neurochem., 71, 302, 10.1046/j.1471-4159.1998.71010302.x Maridonneau-Parini, 1986, Heterogeneous effect of flavonoids on K+ loss and lipid peroxidation induced by oxygen-free radicals in human red cells, Pharmacol. Res. Commun., 18, 61, 10.1016/0031-6989(86)90159-1 Mazzola, 2001, Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer’s disease and in Huntington’s disease fibroblasts, J. Neurochem., 76, 442, 10.1046/j.1471-4159.2001.00033.x Mazzola, 2002, Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders, Neurotoxicology, 23, 603, 10.1016/S0161-813X(02)00062-1 Mazzola, 2003, Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer’s disease fibroblasts, J. Neurosci. Res., 71, 279, 10.1002/jnr.10484 Mira, 2002, Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity, Free Radical Res., 36, 1199, 10.1080/1071576021000016463 Morel, 1994, Role of flavonoids and iron chelation in antioxidant action, Methods Enzymol., 234, 437, 10.1016/0076-6879(94)34114-1 Olsen, 1975, Sequence variability and structure of d-glyceraldehyde-3-phosphate dehydrogenase, J. Biol. Chem., 250, 9313, 10.1016/S0021-9258(19)40645-5 Perry, 2002, Alzheimer disease and oxidative stress, J. Biomed. Biotechnol., 2, 120, 10.1155/S1110724302203010 Potapovich, 2003, Comparative study of antioxidant properties and cytoprotective activity of flavonoids, Biochemistry (Mosc.), 68, 514, 10.1023/A:1023947424341 Schmalhausen, 1999, Mildly oxidized GAPDH: the coupling of the dehydrogenase and acyl phosphatase activities, FEBS Lett., 452, 219, 10.1016/S0014-5793(99)00627-4 Schmalhausen, 2003, Ascorbate-induced oxidation of glyceraldehyde-3-phosphate dehydrogenase, Biochem. Biophys. Res. Commun., 308, 492, 10.1016/S0006-291X(03)01421-9 Scopes, 1982, Purification of all glycolytic enzymes from one muscle extract, Methods Enzymol., 90, 479, 10.1016/S0076-6879(82)90175-6 Sergediene, 1999, Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure–activity relationships, FEBS Lett., 462, 392, 10.1016/S0014-5793(99)01561-6 Smith, 1991, Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease, PNAS, 88, 10540, 10.1073/pnas.88.23.10540 Sugihara, 1999, Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid, Free Radical Biol. Med., 27, 1313, 10.1016/S0891-5849(99)00167-7 Sunaga, 1995, Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer’s brain, Neurisci. Lett., 200, 133, 10.1016/0304-3940(95)12098-O Terao, 1994, Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers, Arch. Biochem. Biophys., 308, 278, 10.1006/abbi.1994.1039 Zhao, 2004, Hemin/nitrite/H2O2 induces brain homogenate oxidation and nitration: effects of some flavonoids, Biochim. Biophys. Acta, 1675, 105, 10.1016/j.bbagen.2004.08.011